These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25701612)

  • 1. Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.
    Zhang W; Wang G; See E; Shaw JP; Baguley BC; Liu J; Amirapu S; Wu Z
    J Control Release; 2015 Apr; 203():161-9. PubMed ID: 25701612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.
    See E; Zhang W; Liu J; Svirskis D; Baguley BC; Shaw JP; Wang G; Wu Z
    Int J Pharm; 2014 Oct; 473(1-2):528-35. PubMed ID: 25079434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving drug retention in liposomes by aging with the aid of glucose.
    Zhang W; Falconer JR; Baguley BC; Shaw JP; Kanamala M; Xu H; Wang G; Liu J; Wu Z
    Int J Pharm; 2016 May; 505(1-2):194-203. PubMed ID: 27021465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
    Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
    Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy.
    Zhang W; Li C; Jin Y; Liu X; Wang Z; Shaw JP; Baguley BC; Wu Z; Liu J
    Drug Deliv; 2018 Nov; 25(1):611-622. PubMed ID: 29493300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer drug.
    Zhang W; Wang G; Falconer JR; Baguley BC; Shaw JP; Liu J; Xu H; See E; Sun J; Aa J; Wu Z
    Pharm Res; 2015 Apr; 32(4):1451-61. PubMed ID: 25355460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs.
    El Kechai N; Bochot A; Huang N; Nguyen Y; Ferrary E; Agnely F
    Int J Pharm; 2015 Jun; 487(1-2):187-96. PubMed ID: 25882015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
    Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
    J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells.
    Yang MM; Wilson WR; Wu Z
    Int J Pharm; 2017 Jan; 516(1-2):323-333. PubMed ID: 27871834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.
    Ganta S; Paxton JW; Baguley BC; Garg S
    Int J Pharm; 2009 Feb; 367(1-2):179-86. PubMed ID: 18848873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melittin liposomes surface modified with poloxamer 188: in vitro characterization and in vivo evaluation.
    Tian JL; Ke X; Chen Z; Wang CJ; Zhang Y; Zhong TC
    Pharmazie; 2011 May; 66(5):362-7. PubMed ID: 21699070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
    J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
    Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
    J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate.
    Zhang J; Chen Y; Li X; Liang X; Luo X
    Int J Nanomedicine; 2016; 11():4187-97. PubMed ID: 27616886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
    Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
    J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina.
    Geng S; Yang B; Wang G; Qin G; Wada S; Wang JY
    Nanotechnology; 2014 Jul; 25(27):275103. PubMed ID: 24960297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.